Drugs / ROSIPTOR
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT03478020 | Nov 2017 → Mar 2018 | — | Aquinox Pharmaceuticals (Canada) Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03185195 | Nov 2016 → Jan 2017 | — | Aquinox Pharmaceuticals (Canada) Inc. | Completed | No outcome recorded |
| Phase 24 trials · 3 missed | ||||||
| Phase 2 | NCT03500159 | Apr → Jul 2018 | chronic pain syndrome, chronic prostatitis | Aquinox Pharmaceuticals (Canada) Inc. | Terminated | No outcome recorded |
| Phase 2 | NCT02324972 | Dec 2014 → Nov 2015 | atopic eczema | Aquinox Pharmaceuticals (Canada) Inc. | Completed | Missed primary |
| Phase 2 | NCT01954628 | Oct 2013 → Jul 2015 | chronic obstructive pulmonary disease | Aquinox Pharmaceuticals (Canada) Inc. | Completed | Missed primary |
| Phase 2 | NCT01882543 | Jun 2013 → Jun 2015 | interstitial cystitis | Aquinox Pharmaceuticals (Canada) Inc. | Completed | Missed primary |
| Phase 31 trial | ||||||
| Phase 3 | NCT02858453 | Jul 2016 → Aug 2018 | interstitial cystitis | Aquinox Pharmaceuticals (Canada) Inc. | Unknown | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ROSIPTOR | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989954 ↗ |
| Known as | AQX-1125 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02858453 ↗ |
| Known as | AQX-1125 acetate | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989954 ↗ |
| Known as | AQX-1125 free base | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989954 ↗ |
| Known as | ROSIPTOR ACETATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989954 ↗ |
| Action | Activate | “Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator” CHEMBL3989954 ↗1“Synthetic SHIP1 activator” NCT01882543 ↗ |
| Modality | Small molecule | — CHEMBL3989954 ↗ |
| Route | Oral | “two doses of oral AQX-1125” NCT02858453 ↗ |
| Target | INPP5D | “Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator” CHEMBL3989954 ↗ |